PDT Partners’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-124,177
| Closed | -$1.96M | – | 567 |
|
|
2018
Q2 | $1.96M | Buy |
124,177
+1,277
| +1% | +$20.2K | 0.07% | 260 |
|
|
2018
Q1 | $1.56M | Sell |
122,900
-230,200
| -65% | -$2.92M | 0.05% | 314 |
|
|
2017
Q4 | $4.04M | Sell |
353,100
-87,388
| -20% | -$1M | 0.12% | 215 |
|
|
2017
Q3 | $5.4M | Buy |
+440,488
| New | +$5.4M | 0.18% | 173 |
|
|
2016
Q1 | – | Sell |
-45,355
| Closed | -$1.5M | – | 616 |
|
|
2015
Q4 | $1.5M | Buy |
45,355
+7,355
| +19% | +$243K | 0.21% | 174 |
|
|
2015
Q3 | $1.25M | Sell |
38,000
-15,358
| -29% | -$503K | 0.03% | 645 |
|
|
2015
Q2 | $2.83M | Buy |
53,358
+11,958
| +29% | +$633K | 0.07% | 318 |
|
|
2015
Q1 | $1.2M | Buy |
41,400
+29,198
| +239% | +$843K | 0.03% | 714 |
|
|
2014
Q4 | $355K | Sell |
12,202
-712
| -6% | -$20.7K | 0.03% | 501 |
|
|
2014
Q3 | $164K | Buy |
+12,914
| New | +$164K | ﹤0.01% | 1209 |
|